Last reviewed · How we verify
exosome
At a glance
| Generic name | exosome |
|---|---|
| Also known as | EVs |
| Sponsor | Isfahan University of Medical Sciences |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias (NA)
- Exosomes Effect on Visual Function in CVI
- Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients
- Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms in Treatment-Resistant Schizophrenia: A Pilot Study (EARLY_PHASE1)
- Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes
- Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis (NA)
- Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction (PHASE2, PHASE3)
- Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- exosome CI brief — competitive landscape report
- exosome updates RSS · CI watch RSS
- Isfahan University of Medical Sciences portfolio CI